| FibroGen Reports Proof-of-Principle for Oral Anemia Therapy FG-4592 in ... - Business Wire (press release) |
|
|
Business Wire (press release) “These results represent the first proof-of-principle that FG-4592 can maintain or increase hemoglobin levels in patients with ESRD on hemodialysis using doses that have been shown to be effective in studies of nondialysis patients with chronic kidney |